Hepatocellular Carcinoma: Portuguese Data in Chronic Hepatitis B Patients on Antiviral Therapy and Treatment Results With Sorafenib

Hepatocellular Carcinoma: Portuguese Data in Chronic Hepatitis B Patients on Antiviral Therapy and Treatment Results With Sorafenib

Bibliographic Details
Main Author:	Adélia Simão
Format:	Article
Language:	English
Published:	Karger Publishers 2016-09-01
Series:	GE: Portuguese Journal of Gastroenterology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2341454516300503

Similar Items

Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis
by: D T Abdurakhmanov
Published: (2013-10-01)

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
by: Ioannis Varbobitis, et al.
Published: (2016-09-01)

Evaluation of Sorafenib therapy in hepatocellular carcinoma
by: Ana Margarida da Cruz Alves
Published: (2019)

Sorafenib, a systemic therapy for hepatocellular carcinoma
by: Nahum Méndez-Sánchez;, et al.
Published: (2008-01-01)

Recommendation on antiviral therapy to hepatitis B/C virus related hepatocellular carcinoma
by: Liver Cancer Study Group，Chinese Society of Hepatology，Chinese Medical Association
Published: (2013-01-01)

Effect of entecavir antiviral therapy alone or combined with interferon on the risk of hepatocellular carcinoma in patients with chronic hepatitis B
by: SUN Jing
Published: (2020-09-01)

Explanation of the “Recommendation on antiviral therapy to hepatitis B/C virus related hepatocellular carcinoma”
by: DONG Jing
Published: (2013-01-01)

Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy
by: Yang Ke, et al.
Published: (2013-09-01)

Secondary prevention of hepatitis B virus‐related hepatocellular carcinoma with current antiviral therapies
by: Jonggi Choi, et al.
Published: (2021-04-01)

Sorafenib and 2-Deoxyglucose: The Future of Hepatocellular Carcinoma Therapy
by: Reyes, Ryan
Published: (2016)

Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma
by: Yang Zhao, et al.
Published: (2019-05-01)

Explanation of the “Expert consensus on antiviral therapy to hepatitis B/C virus-related hepatocellular carcinoma”
by: DONG Jing
Published: (2014-07-01)

The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma
by: Fei-Xiang Wu, et al.
Published: (2017-09-01)

Antiviral therapy of chronic hepatitis B in children
by: ZHU Shishu, et al.
Published: (2015-08-01)

Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure.
by: I-Cheng Lee, et al.
Published: (2017-01-01)

Sorafenib in the treatment of advanced hepatocellular carcinoma
by: Mousa Ali
Published: (2008-01-01)

Sorafenib for the treatment of unresectable hepatocellular carcinoma
by: Junji Furuse
Published: (2008-11-01)

Sorafenib for the treatment of advanced hepatocellular carcinoma
by: M Connock, et al.
Published: (2010-05-01)

Prognostic Nomogram for Sorafenib Benefit in Hepatitis B Virus-Related Hepatocellular Carcinoma After Partial Hepatectomy
by: Wei Dong, et al.
Published: (2021-02-01)

Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan
by: Chen-Ta Chi, et al.
Published: (2021-06-01)

Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
by: Kazuomi Ueshima, et al.
Published: (2020-07-01)

Impact of direct-acting antiviral therapy for hepatitis C-related hepatocellular carcinoma.
by: Wei-Chen Lin, et al.
Published: (2020-01-01)

Antiviral therapy for hepatitis virus-related hepatocellular carcinoma: current status and challenges
by: DONG Jing, et al.
Published: (2017-07-01)

Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma.
by: Aaron T Wild, et al.
Published: (2013-01-01)

Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis
by: Chang Seok Bang, et al.
Published: (2017-04-01)

Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
by: Seong Kyun Na, et al.
Published: (2019-09-01)

Evaluation of Clinical Outcome for Entecarvir Antiviral Drug Treatment in Chronic Hepatitis B-Induced Hepatocellular Carcinoma Patients
by: Hsiang-Chun Chen, et al.
Published: (2016)

Sorafenib use in hepatitis B virus‐ or hepatitis C virus‐related hepatocellular carcinoma: A propensity score matching study
by: Yu‐Chi Lee, et al.
Published: (2021-10-01)

Perfusion Magnetic Resonance as a Biomarker for Sorafenib-Treated Advanced Hepatocellular Carcinoma: A Pilot Study
by: Marta Campos, et al.
Published: (2019-02-01)

Radiosensitization effect of Sorafenib in hepatocellular carcinoma treatment
by: John Chun-Hao Chen, et al.
Published: (2018)

Cost effectiveness of sorafenib for advanced hepatocellular carcinoma
by: Jung-Chen Ho, et al.
Published: (2017)

Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
by: Yi-Ling Ko, et al.
Published: (2020-04-01)

Safety and efficacy of sorafenib in the treatment of hepatocellular carcinoma
by: Khaldoun Almhanna, et al.
Published: (2009-11-01)

Cerebrovascular Accidents Associated with Sorafenib in Hepatocellular Carcinoma
by: Muhammad W. Saif, et al.
Published: (2011-01-01)

Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus
by: Zhang YF, et al.
Published: (2016-07-01)

Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C
by: Chung Sang Tse, et al.
Published: (2021-01-01)

Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves
by: El Kassas M, et al.
Published: (2019-11-01)

Successful antiviral therapy for chronic hepatitis C in a patient after surgery for hepatocellular carcinoma (a clinical observation)
by: I. G. Nikitin, et al.
Published: (2018-08-01)

Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
by: Sojung Han, et al.
Published: (2020-07-01)

Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions
by: Ray EM, et al.
Published: (2017-11-01)

Cannot write session to /tmp/vufind_sessions/sess_k5neanqqm4o9r5loa1mtar1gf4